Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
71.81 USD | +1.03% | -1.29% | +8.54% |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- One of the major weak points of the company is its financial situation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.54% | 50.69B | B+ | ||
+10.00% | 76.32B | B- | ||
+2.63% | 48.13B | B | ||
+10.52% | 42.08B | B+ | ||
+7.56% | 39.7B | B+ | ||
+19.86% | 38.01B | B | ||
+2.50% | 29.79B | B | ||
-6.98% | 27.63B | B- | ||
-20.54% | 24.06B | A- | ||
+10.38% | 22.72B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MET Stock
- Ratings MetLife, Inc.